A report has revealed that a prominent Vancouver researcher allegedly manipulated data and concealed information regarding infected wounds to falsely assert the effectiveness of his patented skin treatment in healing long-standing bed sores. The leaked document implicates University of British Columbia (UBC) plastic surgery professor Aziz Ghahary in presenting falsified results, violating conflict of interest rules, and engaging in bullying behavior during a trial for the skin substitute called Meshfill.
The investigative report, authored by a UBC-appointed committee in March 2021, accuses Ghahary of compromising his scholarly integrity to promote Meshfill as a remedy for chronic pressure ulcer wounds, commonly known as bed sores. Despite his public proclamations of success, none of the pressure wounds in the study had actually healed, and some had even worsened due to infections.
Following the investigation, Ghahary departed from UBC, where he had been employed since 2005. The lack of transparency surrounding these findings has raised concerns among experts, with calls for accountability and full disclosure to study participants.
Meshfill, the product in question, never made it to the Canadian market and should not be confused with cosmetic procedures available online. Jocelyn Maffin of Spinal Cord Injury B.C. expressed disappointment at the false hopes created by the misrepresented claims about Meshfill’s effectiveness in treating pressure ulcer wounds.
The investigation into Ghahary’s conduct began in 2019 following complaints from Dr. Anthony Papp, a collaborator on the Meshfill pilot study. The probe revealed instances of data manipulation, breaches of protocol, and attempts to mislead about the study’s outcomes. Despite the investigation’s findings, questions remain regarding the lack of institutional reforms and transparency in addressing such misconduct.
The mishandling of the Meshfill trial has not only cast doubt on the integrity of scientific research but also highlighted the potential repercussions of misleading information in the healthcare sector. The need for accountability and transparency in research practices is paramount to uphold public trust in scientific advancements and medical treatments.